NCT03438500

Cardiac Shock Wave Treatment in Patients With Reduced Coronary Flow Reserve

The Impact of Cardiac Shock Wave Treatment in Patients With Reduced Coronary Flow Reserve in the Absence of Epicardial Coronary Artery Stenoses: A Pilot Study

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Storz Medical AG · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to assess the feasibility of Cardiac Shock Wave Treatment in patients with anginal chest pain and evidence of abnormal myocardial perfusion under stress in the absence of significant stenoses of the epicardial coronary arteries.

Detailed description

This is a mono-center, prospective, single arm, pilot study designed to assess the feasibility of the "Cardiac Shock Wave Treatment" in patients with anginal chest pain and evidence of abnormal myocardial perfusion under stress in the absence of significant stenoses of the epicardial coronary arteries. A total of 10 subjects will be enrolled in the study. All enrolled study subjects will be assessed for clinical follow-up at the following intervals: 5 and 14 weeks post CSWT procedure.

Conditions

• Refractory Angina Pectoris
• Ischemic Heart Disease
• Coronary Artery Disease

Interventions

Type	Name	Description
DEVICE	Cardiac Extracorporeal Shockwave Therapy (Modulith SLC)	40 - 60 spots per visit (200 shots/spot) at Energy Level 3

Timeline

• Start date: 2022-09-01
• Primary completion: 2022-09-01
• Completion: 2022-09-01
• First posted: 2018-02-19
• Last updated: 2022-10-31

Locations

1 site across 1 country: Germany